Owens & Minor, Inc. (OMI) 10-Year Financial Performance & Capital Metrics

OMI • • Industrial / General

HealthcareMedical DistributionMedical-Surgical DistributionHospital & Surgical Supply Distributors

AboutOwens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.Show more

Revenue $10.7B +3.6%
EBITDA $57M -85.5%
Net Income -$363M -778.2%
EPS (Diluted) -4.73 -760.0%
Gross Margin 20.74% +0.8%
EBITDA Margin 0.53% -86.0%
Operating Margin -1.94% -292.0%
Net Margin -3.39% -748.0%
ROE -48.7% -1002.4%
ROIC -5.43% -333.9%
Debt/Equity 3.79 +45.4%
Interest Coverage -1.44 -318.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading at only 0.3x book value
✓Efficient asset utilization: 2.3x turnover

✗Weaknesses

✗High debt to equity ratio of 3.8x
✗Negative free cash flow
✗Weak momentum: RS Rating 7 (bottom 7%)
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y1.26%

5Y3.04%

3Y3.03%

TTM44.52%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-2647.63%

EPS CAGR

10Y-

5Y-

3Y-

TTM-2576.92%

ROCE

10Y Avg4.15%

5Y Avg5.62%

3Y Avg0.26%

Latest-6.94%

Peer Comparison

Hospital & Surgical Supply Distributors

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
GEGGreat Elm Group, Inc.	79.6M	2.41	7.30	-8.51%	13.94%	3.88%		0.78
OMIOwens & Minor, Inc.	195.69M	2.53	-0.53	3.55%	-19.98%	-48.7%		3.79

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	9.77B	9.72B	9.32B	9.84B	9.21B	8.48B	9.79B	9.96B	10.33B	10.7B
Revenue Growth %	0.04%	-0.01%	-0.04%	0.06%	-0.06%	-0.08%	0.15%	0.02%	0.04%	0.04%
Cost of Goods Sold+	8.56B	8.54B	8.15B	8.47B	8.08B	7.2B	8.27B	8.13B	8.21B	8.48B
COGS % of Revenue	0.88%	0.88%	0.87%	0.86%	0.88%	0.85%	0.85%	0.82%	0.79%	0.79%
Gross Profit+	1.21B	1.19B	1.17B	1.37B	1.13B	1.28B	1.51B	1.83B	2.13B	2.22B
Gross Margin %	0.12%	0.12%	0.13%	0.14%	0.12%	0.15%	0.15%	0.18%	0.21%	0.21%
Gross Profit Growth %	0.04%	-0.02%	-0.01%	0.17%	-0.17%	0.13%	0.18%	0.21%	0.16%	0.04%
Operating Expenses+	985.81M	963.04M	1.02B	1.26B	1.06B	1.08B	1.14B	1.68B	2.02B	2.43B
OpEx % of Revenue	0.1%	0.1%	0.11%	0.13%	0.11%	0.13%	0.12%	0.17%	0.2%	0.23%
Selling, General & Admin	933.6M	970.42M	1.02B	1.26B	1.02B	1.04B	1.08B	1.55B	1.81B	1.91B
SG&A % of Revenue	0.1%	0.1%	0.11%	0.13%	0.11%	0.12%	0.11%	0.16%	0.18%	0.18%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	52.21M	-7.39M	4.93M	-4.42M	30.67M	34.05M	67.69M	128.62M	207.09M	517.13M
Operating Income+	200.36M	199.6M	89.25M	-392.17M	73.15M	204.12M	368.47M	142.91M	104.51M	-207.77M
Operating Margin %	0.02%	0.02%	0.01%	-0.04%	0.01%	0.02%	0.04%	0.01%	0.01%	-0.02%
Operating Income Growth %	0.26%	-0%	-0.55%	-5.39%	1.19%	1.79%	0.81%	-0.61%	-0.27%	-2.99%
EBITDA+	266.34M	254.99M	148.69M	-308.77M	160.6M	287.25M	459.09M	371.58M	391.88M	57.01M
EBITDA Margin %	0.03%	0.03%	0.02%	-0.03%	0.02%	0.03%	0.05%	0.04%	0.04%	0.01%
EBITDA Growth %	0.19%	-0.04%	-0.42%	-3.08%	1.52%	0.79%	0.6%	-0.19%	0.05%	-0.85%
D&A (Non-Cash Add-back)	65.98M	55.39M	59.44M	83.4M	87.45M	83.14M	90.62M	228.67M	287.38M	264.77M
EBIT	200.36M	224.27M	149.96M	-356.11M	99.28M	240.28M	324.84M	139.78M	103.19M	250.4M
Net Interest Income+	-27.15M	-27.06M	-31.77M	-70.98M	-98.11M	-83.4M	-48.09M	-128.89M	-157.91M	-143.8M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	27.15M	27.06M	31.77M	70.98M	98.11M	83.4M	48.09M	128.89M	157.91M	143.8M
Other Income/Expense	-27.15M	-27.06M	-31.77M	-74.75M	-101.87M	-94.21M	-91.72M	-132.02M	-159.23M	-149.59M
Pretax Income+	173.21M	172.54M	57.48M	-469.19M	-28.72M	109.91M	276.75M	10.89M	-54.73M	-357.36M
Pretax Margin %	0.02%	0.02%	0.01%	-0.05%	-0%	0.01%	0.03%	0%	-0.01%	-0.03%
Income Tax+	69.8M	63.76M	-15.31M	-32.18M	-6.13M	21.83M	55.16M	-11.5M	-13.43M	5.33M
Effective Tax Rate %	0.6%	0.63%	1.27%	0.93%	2.17%	0.27%	0.8%	2.06%	0.75%	1.01%
Net Income+	103.41M	108.79M	72.79M	-437.01M	-62.37M	29.87M	221.59M	22.39M	-41.3M	-362.69M
Net Margin %	0.01%	0.01%	0.01%	-0.04%	-0.01%	0%	0.02%	0%	-0%	-0.03%
Net Income Growth %	0.55%	0.05%	-0.33%	-7%	0.86%	1.48%	6.42%	-0.9%	-2.84%	-7.78%
Net Income (Continuing)	103.41M	108.79M	72.79M	-394.67M	-22.58M	88.07M	221.59M	22.39M	-41.3M	-362.69M
Discontinued Operations	0	0	0	0	-39.79M	-58.2M	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	1.65	1.76	1.20	-7.28	-0.37	0.47	2.94	0.29	-0.55	-4.73
EPS Growth %	0.56%	0.07%	-0.32%	-7.07%	0.95%	2.27%	5.26%	-0.9%	-2.9%	-7.6%
EPS (Basic)	1.65	1.76	1.20	-7.28	-0.37	0.47	3.05	0.30	-0.55	-4.73
Diluted Shares Outstanding	62.12M	61.09M	60M	60.01M	60.57M	63.51M	75.49M	76.22M	75.78M	76.74M
Basic Shares Outstanding	62.12M	61.09M	60M	60.01M	60.57M	63.37M	72.74M	74.5M	75.78M	76.74M
Dividend Payout Ratio	0.62%	0.58%	0.87%	-	-	0.02%	0%	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.97B	1.96B	2.18B	2.54B	2.41B	2.14B	2.32B	2.3B	2.1B	2.02B
Cash & Short-Term Investments	161.02M	185.49M	104.52M	103.37M	67.03M	118.18M	55.71M	69.47M	243.04M	49.38M
Cash Only	161.02M	185.49M	104.52M	103.37M	67.03M	118.18M	55.71M	69.47M	243.04M	49.38M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	587.93M	606.08M	758.94M	756.69M	674.71M	700.79M	681.56M	763.5M	598.26M	690.24M
Days Sales Outstanding	21.96	22.75	29.73	28.07	26.74	30.16	25.42	27.99	21.13	23.54
Inventory	940.77M	916.31M	990.19M	1.29B	1.15B	1.23B	1.5B	1.33B	1.11B	1.13B
Days Inventory Outstanding	40.12	39.18	44.37	55.58	51.76	62.55	66.01	59.88	49.38	48.71
Other Current Assets	284.97M	254.16M	328.25M	441.86M	519.36M	83.14M	88.56M	128.64M	150.89M	149.51M
Total Non-Current Assets+	803.14M	755.71M	1.19B	1.24B	1.24B	1.2B	1.21B	3.09B	2.99B	2.63B
Property, Plant & Equipment	208.93M	191.72M	206.49M	386.72M	457.65M	460.42M	511.24M	858.93M	840.5M	864.97M
Fixed Asset Turnover	46.78x	50.72x	45.13x	25.44x	20.13x	18.42x	19.14x	11.59x	12.29x	12.37x
Goodwill	419.62M	414.94M	713.81M	414.12M	393.18M	394.09M	390.19M	1.64B	1.64B	1.33B
Intangible Assets	95.25M	82.51M	184.47M	321.76M	285.02M	281.35M	243.75M	483.74M	361.83M	296.73M
Long-Term Investments	0	-90.38M	-74.25M	-50.85M	-40.55M	16.32M	16.32M	15.46M	8.45M	6.11M
Other Non-Current Assets	79.34M	66.55M	89.62M	112.6M	99.96M	47.6M	53.24M	96.26M	149.35M	134.04M
Total Assets+	2.78B	2.72B	3.38B	3.77B	3.64B	3.34B	3.54B	5.39B	5.09B	4.66B
Asset Turnover	3.52x	3.58x	2.76x	2.61x	2.53x	2.54x	2.77x	1.85x	2.03x	2.30x
Asset Growth %	0.02%	-0.02%	0.24%	0.12%	-0.03%	-0.08%	0.06%	0.52%	-0.05%	-0.09%
Total Current Liabilities+	1.06B	1.03B	1.31B	1.47B	1.42B	1.35B	1.34B	1.57B	1.89B	1.87B
Accounts Payable	710.61M	750.75M	947.57M	1.07B	808.03M	1B	1B	1.15B	1.17B	1.25B
Days Payables Outstanding	30.31	32.1	42.46	45.89	36.49	50.71	44.21	51.52	52.11	53.88
Short-Term Debt	0	0	0	28.69M	50.22M	34.5M	43.85M	15.38M	204.08M	40M
Deferred Revenue (Current)	0	0	0	-1000K	1000K	0	0	0	1000K	0
Other Current Liabilities	155.6M	238.84M	203.36M	336.36M	427.26M	201.6M	182.35M	227.44M	191.66M	425.54M
Current Ratio	1.86x	1.90x	1.67x	1.72x	1.70x	1.59x	1.73x	1.47x	1.11x	1.08x
Quick Ratio	0.97x	1.01x	0.91x	0.85x	0.89x	0.67x	0.61x	0.61x	0.52x	0.47x
Cash Conversion Cycle	31.77	29.83	31.64	37.76	42.01	42	47.22	36.35	18.41	18.38
Total Non-Current Liabilities+	721.66M	723.08M	1.05B	1.78B	1.76B	1.28B	1.25B	2.87B	2.28B	2.22B
Long-Term Debt	568.5M	564.58M	900.74M	1.65B	1.51B	975.89M	936.23M	2.47B	1.88B	1.8B
Capital Lease Obligations	0	0	0	0	117.08M	130.06M	173.56M	227.35M	231.99M	295.49M
Deferred Tax Liabilities	86.33M	90.38M	74.25M	50.85M	40.55M	50.64M	35.31M	0	41.65M	22.46M
Other Non-Current Liabilities	62.78M	68.11M	76.09M	81.92M	98.73M	121.27M	108.94M	175.78M	122.59M	100.13M
Total Liabilities	1.79B	1.76B	2.36B	3.26B	3.18B	2.62B	2.6B	4.44B	4.17B	4.09B
Total Debt+	572.56M	564.58M	900.74M	1.65B	1.71B	1.14B	1.15B	2.79B	2.41B	2.14B
Net Debt	411.54M	379.1M	796.22M	1.55B	1.64B	1.02B	1.1B	2.72B	2.16B	2.09B
Debt / Equity	0.58x	0.59x	0.89x	3.18x	3.70x	1.60x	1.23x	2.95x	2.60x	3.79x
Debt / EBITDA	2.15x	2.21x	6.06x	-	10.64x	3.97x	2.51x	7.52x	6.14x	37.54x
Net Debt / EBITDA	1.55x	1.49x	5.35x	-	10.22x	3.56x	2.39x	7.33x	5.52x	36.67x
Interest Coverage	7.38x	7.38x	2.81x	-5.52x	0.75x	2.45x	7.66x	1.11x	0.66x	-1.44x
Total Equity+	992.59M	960.04M	1.02B	518.42M	462.15M	712.05M	938.5M	945.6M	924.17M	565.23M
Equity Growth %	0%	-0.03%	0.06%	-0.49%	-0.11%	0.54%	0.32%	0.01%	-0.02%	-0.39%
Book Value per Share	15.98	15.71	16.92	8.64	7.63	11.21	12.43	12.41	12.19	7.37
Total Shareholders' Equity	992.59M	960.04M	1.02B	518.42M	462.15M	712.05M	938.5M	945.6M	924.17M	565.23M
Common Stock	125.61M	122.06M	122.95M	124.59M	125.69M	146.94M	150.87M	152.56M	153.09M	154.4M
Retained Earnings	706.87M	685.5M	690.67M	200.67M	137.77M	167.02M	387.62M	410.01M	368.71M	6.02M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-51.83M	-67.48M	-25.08M	-45.61M	-52.71M	-38.51M	-40.59M	-35.85M	-31.82M	-49.34M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	269.6M	186.93M	56.77M	115.59M	166.09M	339.22M	124.18M	325.01M	740.71M	161.5M
Operating CF Margin %	0.03%	0.02%	0.01%	0.01%	0.02%	0.04%	0.01%	0.03%	0.07%	0.02%
Operating CF Growth %	72.68%	-0.31%	-0.7%	1.04%	0.44%	1.04%	-0.63%	1.62%	1.28%	-0.78%
Net Income	103.41M	108.79M	72.79M	-437.01M	-62.37M	29.87M	221.59M	22.39M	-41.3M	-362.69M
Depreciation & Amortization	65.98M	55.39M	59.44M	101.93M	116.68M	93.34M	90.62M	228.67M	287.38M	264.77M
Stock-Based Compensation	11.31M	12.04M	11.91M	16.38M	15.8M	20.01M	25.02M	20.99M	23.22M	26.84M
Deferred Taxes	-6.1M	4.22M	-49.99M	-35.02M	-17.4M	15.56M	-29.74M	-26.36M	-23.65M	-26.11M
Other Non-Cash Items	2.21M	3.28M	8.97M	455.09M	52.76M	101.9M	78.09M	-10.45M	-27.22M	284.12M
Working Capital Changes	92.79M	3.22M	-46.36M	14.23M	60.62M	78.55M	-261.4M	89.77M	522.29M	-25.44M
Change in Receivables	18.33M	-25.24M	-100.01M	11.11M	63.53M	-34.82M	-2.2M	1.1M	166.58M	-94.55M
Change in Inventory	-69.73M	22.59M	-57.03M	-65.45M	127.92M	-85.15M	-263.44M	166.56M	224.34M	-26.23M
Change in Payables	103.52M	43.43M	143.95M	92.18M	-235.63M	193.24M	3.55M	13.65M	31M	65.19M
Cash from Investing+	-36.47M	-24.75M	-416.64M	-815.83M	-51.9M	80.07M	-53.63M	-1.8B	-137.25M	-116.53M
Capital Expenditures	-36.62M	-30.12M	-50.74M	-65.69M	-42.42M	-50.42M	-49.69M	-166.58M	-190.87M	-210.87M
CapEx % of Revenue	0%	0%	0.01%	0.01%	0%	0.01%	0.01%	0.02%	0.02%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	143K	5.38M	663K	1.69M	-9.48M	-2.5M	39.43M	46.71M	53.62M	94.33M
Cash from Financing+	-124.23M	-141.94M	272.81M	701.07M	-130.2M	-379.39M	-129.48M	1.5B	-417.33M	-267.6M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-63.65M	-63.38M	-63.15M	-48.2M	-5.23M	-648K	-731K	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-6.88M	-7.53M	-10.52M	-35.73M	-7.18M	-26.86M	-33.4M	-85.39M	-637K	-23.41M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	232.98M	156.81M	6.04M	49.9M	113.86M	280.03M	74.49M	158.42M	532.82M	-66.67M
FCF Margin %	0.02%	0.02%	0%	0.01%	0.01%	0.03%	0.01%	0.02%	0.05%	-0.01%
FCF Growth %	4.12%	-0.33%	-0.96%	7.27%	1.28%	1.46%	-0.73%	1.13%	2.36%	-1.13%
FCF per Share	3.75	2.57	0.10	0.83	1.88	4.41	0.99	2.08	7.03	-0.87
FCF Conversion (FCF/Net Income)	2.61x	1.72x	0.78x	-0.26x	-2.66x	11.36x	0.56x	14.52x	-17.93x	-0.45x
Interest Paid	0	0	0	68.58M	95.41M	89.96M	38.72M	107.02M	153.25M	141.55M
Taxes Paid	0	0	0	19.15M	6.2M	17.45M	99.4M	33.97M	6.28M	5.55M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	10.43%	11.14%	7.37%	-56.98%	-12.72%	5.09%	26.85%	2.38%	-4.42%	-48.7%
Return on Invested Capital (ROIC)	10.2%	10.91%	4.25%	-15.17%	2.63%	7.98%	14.66%	3.76%	2.32%	-5.43%
Gross Margin	12.43%	12.21%	12.58%	13.89%	12.25%	15.1%	15.46%	18.35%	20.56%	20.74%
Net Margin	1.06%	1.12%	0.78%	-4.44%	-0.68%	0.35%	2.26%	0.22%	-0.4%	-3.39%
Debt / Equity	0.58x	0.59x	0.89x	3.18x	3.70x	1.60x	1.23x	2.95x	2.60x	3.79x
Interest Coverage	7.38x	7.38x	2.81x	-5.52x	0.75x	2.45x	7.66x	1.11x	0.66x	-1.44x
FCF Conversion	2.61x	1.72x	0.78x	-0.26x	-2.66x	11.36x	0.56x	14.52x	-17.93x	-0.45x
Revenue Growth	3.52%	-0.51%	-4.17%	5.59%	-6.38%	-7.93%	15.39%	1.74%	3.8%	3.55%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Products & Healthcare Services	-	-	-	-	-	-	-	7.9B	7.78B	8.02B
Products & Healthcare Services Growth	-	-	-	-	-	-	-	-	-1.48%	3.08%
Patient Direct	-	-	-	-	-	-	-	2.06B	2.55B	2.68B
Patient Direct Growth	-	-	-	-	-	-	-	-	24.09%	5.00%
Global Solutions	-	-	-	9.19B	8.24B	7.21B	7.86B	-	-	-
Global Solutions Growth	-	-	-	-	-10.28%	-12.52%	8.99%	-	-	-
Global Products	-	-	-	1.11B	1.43B	1.81B	2.66B	-	-	-
Global Products Growth	-	-	-	-	29.03%	26.25%	46.70%	-	-	-
Domestic	9.36B	9.19B	8.79B	-	-	-	-	-	-	-
Domestic Growth	-	-1.76%	-4.32%	-	-	-	-	-	-	-
CPS	-	539.58M	504.03M	-	-	-	-	-	-	-
CPS Growth	-	-	-6.59%	-	-	-	-	-	-	-
International	416.81M	343.67M	391.63M	-	-	-	-	-	-	-
International Growth	-	-17.55%	13.95%	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	9.36B	9.34B	8.9B	9.26B	8.87B	8.13B	9.25B	9.53B	10.06B	10.46B
UNITED STATES Growth	-	-0.19%	-4.70%	4.07%	-4.21%	-8.35%	13.77%	2.98%	5.59%	3.97%
Non-US	-	-	-	577.56M	339.34M	349.77M	534.98M	429.44M	275.29M	242.94M
Non-US Growth	-	-	-	-	-41.25%	3.07%	52.95%	-19.73%	-35.89%	-11.75%
Other Europe	132.55M	87.53M	97.92M	-	-	-	-	-	-	-
Other Europe Growth	-	-33.97%	11.88%	-	-	-	-	-	-	-
IRELAND	-	41.21M	56.94M	-	-	-	-	-	-	-
IRELAND Growth	-	-	38.15%	-	-	-	-	-	-	-
GERMANY	46.85M	47.51M	49.23M	-	-	-	-	-	-	-
GERMANY Growth	-	1.42%	3.61%	-	-	-	-	-	-	-
FRANCE	44.59M	38.76M	39.28M	-	-	-	-	-	-	-
FRANCE Growth	-	-13.08%	1.34%	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Owens & Minor, Inc. (OMI) reported $6.71B in revenue for fiscal year 2024. This represents a 22% decrease from $8.63B in 2011.

Owens & Minor, Inc. (OMI) grew revenue by 3.6% over the past year. Growth has been modest.

Owens & Minor, Inc. (OMI) reported a net loss of $1.34B for fiscal year 2024.

Dividend & Returns

Owens & Minor, Inc. (OMI) has a return on equity (ROE) of -48.7%. Negative ROE indicates the company is unprofitable.

Owens & Minor, Inc. (OMI) had negative free cash flow of $352.2M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Owens & Minor, Inc. (OMI) 10-Year Financial Performance & Capital Metrics

OMI • • Industrial / General

HealthcareMedical DistributionMedical-Surgical DistributionHospital & Surgical Supply Distributors

Revenue $10.7B +3.6%
EBITDA $57M -85.5%
Net Income -$363M -778.2%
EPS (Diluted) -4.73 -760.0%
Gross Margin 20.74% +0.8%
EBITDA Margin 0.53% -86.0%
Operating Margin -1.94% -292.0%
Net Margin -3.39% -748.0%
ROE -48.7% -1002.4%
ROIC -5.43% -333.9%
Debt/Equity 3.79 +45.4%
Interest Coverage -1.44 -318.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading at only 0.3x book value
✓Efficient asset utilization: 2.3x turnover

✗Weaknesses

✗High debt to equity ratio of 3.8x
✗Negative free cash flow
✗Weak momentum: RS Rating 7 (bottom 7%)
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y1.26%

5Y3.04%

3Y3.03%

TTM44.52%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-2647.63%

EPS CAGR

10Y-

5Y-

3Y-

TTM-2576.92%

ROCE

10Y Avg4.15%

5Y Avg5.62%

3Y Avg0.26%

Latest-6.94%

Peer Comparison

Hospital & Surgical Supply Distributors

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
GEGGreat Elm Group, Inc.	79.6M	2.41	7.30	-8.51%	13.94%	3.88%		0.78
OMIOwens & Minor, Inc.	195.69M	2.53	-0.53	3.55%	-19.98%	-48.7%		3.79

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	9.77B	9.72B	9.32B	9.84B	9.21B	8.48B	9.79B	9.96B	10.33B	10.7B
Revenue Growth %	0.04%	-0.01%	-0.04%	0.06%	-0.06%	-0.08%	0.15%	0.02%	0.04%	0.04%
Cost of Goods Sold+	8.56B	8.54B	8.15B	8.47B	8.08B	7.2B	8.27B	8.13B	8.21B	8.48B
COGS % of Revenue	0.88%	0.88%	0.87%	0.86%	0.88%	0.85%	0.85%	0.82%	0.79%	0.79%
Gross Profit+	1.21B	1.19B	1.17B	1.37B	1.13B	1.28B	1.51B	1.83B	2.13B	2.22B
Gross Margin %	0.12%	0.12%	0.13%	0.14%	0.12%	0.15%	0.15%	0.18%	0.21%	0.21%
Gross Profit Growth %	0.04%	-0.02%	-0.01%	0.17%	-0.17%	0.13%	0.18%	0.21%	0.16%	0.04%
Operating Expenses+	985.81M	963.04M	1.02B	1.26B	1.06B	1.08B	1.14B	1.68B	2.02B	2.43B
OpEx % of Revenue	0.1%	0.1%	0.11%	0.13%	0.11%	0.13%	0.12%	0.17%	0.2%	0.23%
Selling, General & Admin	933.6M	970.42M	1.02B	1.26B	1.02B	1.04B	1.08B	1.55B	1.81B	1.91B
SG&A % of Revenue	0.1%	0.1%	0.11%	0.13%	0.11%	0.12%	0.11%	0.16%	0.18%	0.18%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	52.21M	-7.39M	4.93M	-4.42M	30.67M	34.05M	67.69M	128.62M	207.09M	517.13M
Operating Income+	200.36M	199.6M	89.25M	-392.17M	73.15M	204.12M	368.47M	142.91M	104.51M	-207.77M
Operating Margin %	0.02%	0.02%	0.01%	-0.04%	0.01%	0.02%	0.04%	0.01%	0.01%	-0.02%
Operating Income Growth %	0.26%	-0%	-0.55%	-5.39%	1.19%	1.79%	0.81%	-0.61%	-0.27%	-2.99%
EBITDA+	266.34M	254.99M	148.69M	-308.77M	160.6M	287.25M	459.09M	371.58M	391.88M	57.01M
EBITDA Margin %	0.03%	0.03%	0.02%	-0.03%	0.02%	0.03%	0.05%	0.04%	0.04%	0.01%
EBITDA Growth %	0.19%	-0.04%	-0.42%	-3.08%	1.52%	0.79%	0.6%	-0.19%	0.05%	-0.85%
D&A (Non-Cash Add-back)	65.98M	55.39M	59.44M	83.4M	87.45M	83.14M	90.62M	228.67M	287.38M	264.77M
EBIT	200.36M	224.27M	149.96M	-356.11M	99.28M	240.28M	324.84M	139.78M	103.19M	250.4M
Net Interest Income+	-27.15M	-27.06M	-31.77M	-70.98M	-98.11M	-83.4M	-48.09M	-128.89M	-157.91M	-143.8M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	27.15M	27.06M	31.77M	70.98M	98.11M	83.4M	48.09M	128.89M	157.91M	143.8M
Other Income/Expense	-27.15M	-27.06M	-31.77M	-74.75M	-101.87M	-94.21M	-91.72M	-132.02M	-159.23M	-149.59M
Pretax Income+	173.21M	172.54M	57.48M	-469.19M	-28.72M	109.91M	276.75M	10.89M	-54.73M	-357.36M
Pretax Margin %	0.02%	0.02%	0.01%	-0.05%	-0%	0.01%	0.03%	0%	-0.01%	-0.03%
Income Tax+	69.8M	63.76M	-15.31M	-32.18M	-6.13M	21.83M	55.16M	-11.5M	-13.43M	5.33M
Effective Tax Rate %	0.6%	0.63%	1.27%	0.93%	2.17%	0.27%	0.8%	2.06%	0.75%	1.01%
Net Income+	103.41M	108.79M	72.79M	-437.01M	-62.37M	29.87M	221.59M	22.39M	-41.3M	-362.69M
Net Margin %	0.01%	0.01%	0.01%	-0.04%	-0.01%	0%	0.02%	0%	-0%	-0.03%
Net Income Growth %	0.55%	0.05%	-0.33%	-7%	0.86%	1.48%	6.42%	-0.9%	-2.84%	-7.78%
Net Income (Continuing)	103.41M	108.79M	72.79M	-394.67M	-22.58M	88.07M	221.59M	22.39M	-41.3M	-362.69M
Discontinued Operations	0	0	0	0	-39.79M	-58.2M	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	1.65	1.76	1.20	-7.28	-0.37	0.47	2.94	0.29	-0.55	-4.73
EPS Growth %	0.56%	0.07%	-0.32%	-7.07%	0.95%	2.27%	5.26%	-0.9%	-2.9%	-7.6%
EPS (Basic)	1.65	1.76	1.20	-7.28	-0.37	0.47	3.05	0.30	-0.55	-4.73
Diluted Shares Outstanding	62.12M	61.09M	60M	60.01M	60.57M	63.51M	75.49M	76.22M	75.78M	76.74M
Basic Shares Outstanding	62.12M	61.09M	60M	60.01M	60.57M	63.37M	72.74M	74.5M	75.78M	76.74M
Dividend Payout Ratio	0.62%	0.58%	0.87%	-	-	0.02%	0%	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.97B	1.96B	2.18B	2.54B	2.41B	2.14B	2.32B	2.3B	2.1B	2.02B
Cash & Short-Term Investments	161.02M	185.49M	104.52M	103.37M	67.03M	118.18M	55.71M	69.47M	243.04M	49.38M
Cash Only	161.02M	185.49M	104.52M	103.37M	67.03M	118.18M	55.71M	69.47M	243.04M	49.38M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	587.93M	606.08M	758.94M	756.69M	674.71M	700.79M	681.56M	763.5M	598.26M	690.24M
Days Sales Outstanding	21.96	22.75	29.73	28.07	26.74	30.16	25.42	27.99	21.13	23.54
Inventory	940.77M	916.31M	990.19M	1.29B	1.15B	1.23B	1.5B	1.33B	1.11B	1.13B
Days Inventory Outstanding	40.12	39.18	44.37	55.58	51.76	62.55	66.01	59.88	49.38	48.71
Other Current Assets	284.97M	254.16M	328.25M	441.86M	519.36M	83.14M	88.56M	128.64M	150.89M	149.51M
Total Non-Current Assets+	803.14M	755.71M	1.19B	1.24B	1.24B	1.2B	1.21B	3.09B	2.99B	2.63B
Property, Plant & Equipment	208.93M	191.72M	206.49M	386.72M	457.65M	460.42M	511.24M	858.93M	840.5M	864.97M
Fixed Asset Turnover	46.78x	50.72x	45.13x	25.44x	20.13x	18.42x	19.14x	11.59x	12.29x	12.37x
Goodwill	419.62M	414.94M	713.81M	414.12M	393.18M	394.09M	390.19M	1.64B	1.64B	1.33B
Intangible Assets	95.25M	82.51M	184.47M	321.76M	285.02M	281.35M	243.75M	483.74M	361.83M	296.73M
Long-Term Investments	0	-90.38M	-74.25M	-50.85M	-40.55M	16.32M	16.32M	15.46M	8.45M	6.11M
Other Non-Current Assets	79.34M	66.55M	89.62M	112.6M	99.96M	47.6M	53.24M	96.26M	149.35M	134.04M
Total Assets+	2.78B	2.72B	3.38B	3.77B	3.64B	3.34B	3.54B	5.39B	5.09B	4.66B
Asset Turnover	3.52x	3.58x	2.76x	2.61x	2.53x	2.54x	2.77x	1.85x	2.03x	2.30x
Asset Growth %	0.02%	-0.02%	0.24%	0.12%	-0.03%	-0.08%	0.06%	0.52%	-0.05%	-0.09%
Total Current Liabilities+	1.06B	1.03B	1.31B	1.47B	1.42B	1.35B	1.34B	1.57B	1.89B	1.87B
Accounts Payable	710.61M	750.75M	947.57M	1.07B	808.03M	1B	1B	1.15B	1.17B	1.25B
Days Payables Outstanding	30.31	32.1	42.46	45.89	36.49	50.71	44.21	51.52	52.11	53.88
Short-Term Debt	0	0	0	28.69M	50.22M	34.5M	43.85M	15.38M	204.08M	40M
Deferred Revenue (Current)	0	0	0	-1000K	1000K	0	0	0	1000K	0
Other Current Liabilities	155.6M	238.84M	203.36M	336.36M	427.26M	201.6M	182.35M	227.44M	191.66M	425.54M
Current Ratio	1.86x	1.90x	1.67x	1.72x	1.70x	1.59x	1.73x	1.47x	1.11x	1.08x
Quick Ratio	0.97x	1.01x	0.91x	0.85x	0.89x	0.67x	0.61x	0.61x	0.52x	0.47x
Cash Conversion Cycle	31.77	29.83	31.64	37.76	42.01	42	47.22	36.35	18.41	18.38
Total Non-Current Liabilities+	721.66M	723.08M	1.05B	1.78B	1.76B	1.28B	1.25B	2.87B	2.28B	2.22B
Long-Term Debt	568.5M	564.58M	900.74M	1.65B	1.51B	975.89M	936.23M	2.47B	1.88B	1.8B
Capital Lease Obligations	0	0	0	0	117.08M	130.06M	173.56M	227.35M	231.99M	295.49M
Deferred Tax Liabilities	86.33M	90.38M	74.25M	50.85M	40.55M	50.64M	35.31M	0	41.65M	22.46M
Other Non-Current Liabilities	62.78M	68.11M	76.09M	81.92M	98.73M	121.27M	108.94M	175.78M	122.59M	100.13M
Total Liabilities	1.79B	1.76B	2.36B	3.26B	3.18B	2.62B	2.6B	4.44B	4.17B	4.09B
Total Debt+	572.56M	564.58M	900.74M	1.65B	1.71B	1.14B	1.15B	2.79B	2.41B	2.14B
Net Debt	411.54M	379.1M	796.22M	1.55B	1.64B	1.02B	1.1B	2.72B	2.16B	2.09B
Debt / Equity	0.58x	0.59x	0.89x	3.18x	3.70x	1.60x	1.23x	2.95x	2.60x	3.79x
Debt / EBITDA	2.15x	2.21x	6.06x	-	10.64x	3.97x	2.51x	7.52x	6.14x	37.54x
Net Debt / EBITDA	1.55x	1.49x	5.35x	-	10.22x	3.56x	2.39x	7.33x	5.52x	36.67x
Interest Coverage	7.38x	7.38x	2.81x	-5.52x	0.75x	2.45x	7.66x	1.11x	0.66x	-1.44x
Total Equity+	992.59M	960.04M	1.02B	518.42M	462.15M	712.05M	938.5M	945.6M	924.17M	565.23M
Equity Growth %	0%	-0.03%	0.06%	-0.49%	-0.11%	0.54%	0.32%	0.01%	-0.02%	-0.39%
Book Value per Share	15.98	15.71	16.92	8.64	7.63	11.21	12.43	12.41	12.19	7.37
Total Shareholders' Equity	992.59M	960.04M	1.02B	518.42M	462.15M	712.05M	938.5M	945.6M	924.17M	565.23M
Common Stock	125.61M	122.06M	122.95M	124.59M	125.69M	146.94M	150.87M	152.56M	153.09M	154.4M
Retained Earnings	706.87M	685.5M	690.67M	200.67M	137.77M	167.02M	387.62M	410.01M	368.71M	6.02M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-51.83M	-67.48M	-25.08M	-45.61M	-52.71M	-38.51M	-40.59M	-35.85M	-31.82M	-49.34M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	269.6M	186.93M	56.77M	115.59M	166.09M	339.22M	124.18M	325.01M	740.71M	161.5M
Operating CF Margin %	0.03%	0.02%	0.01%	0.01%	0.02%	0.04%	0.01%	0.03%	0.07%	0.02%
Operating CF Growth %	72.68%	-0.31%	-0.7%	1.04%	0.44%	1.04%	-0.63%	1.62%	1.28%	-0.78%
Net Income	103.41M	108.79M	72.79M	-437.01M	-62.37M	29.87M	221.59M	22.39M	-41.3M	-362.69M
Depreciation & Amortization	65.98M	55.39M	59.44M	101.93M	116.68M	93.34M	90.62M	228.67M	287.38M	264.77M
Stock-Based Compensation	11.31M	12.04M	11.91M	16.38M	15.8M	20.01M	25.02M	20.99M	23.22M	26.84M
Deferred Taxes	-6.1M	4.22M	-49.99M	-35.02M	-17.4M	15.56M	-29.74M	-26.36M	-23.65M	-26.11M
Other Non-Cash Items	2.21M	3.28M	8.97M	455.09M	52.76M	101.9M	78.09M	-10.45M	-27.22M	284.12M
Working Capital Changes	92.79M	3.22M	-46.36M	14.23M	60.62M	78.55M	-261.4M	89.77M	522.29M	-25.44M
Change in Receivables	18.33M	-25.24M	-100.01M	11.11M	63.53M	-34.82M	-2.2M	1.1M	166.58M	-94.55M
Change in Inventory	-69.73M	22.59M	-57.03M	-65.45M	127.92M	-85.15M	-263.44M	166.56M	224.34M	-26.23M
Change in Payables	103.52M	43.43M	143.95M	92.18M	-235.63M	193.24M	3.55M	13.65M	31M	65.19M
Cash from Investing+	-36.47M	-24.75M	-416.64M	-815.83M	-51.9M	80.07M	-53.63M	-1.8B	-137.25M	-116.53M
Capital Expenditures	-36.62M	-30.12M	-50.74M	-65.69M	-42.42M	-50.42M	-49.69M	-166.58M	-190.87M	-210.87M
CapEx % of Revenue	0%	0%	0.01%	0.01%	0%	0.01%	0.01%	0.02%	0.02%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	143K	5.38M	663K	1.69M	-9.48M	-2.5M	39.43M	46.71M	53.62M	94.33M
Cash from Financing+	-124.23M	-141.94M	272.81M	701.07M	-130.2M	-379.39M	-129.48M	1.5B	-417.33M	-267.6M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-63.65M	-63.38M	-63.15M	-48.2M	-5.23M	-648K	-731K	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-6.88M	-7.53M	-10.52M	-35.73M	-7.18M	-26.86M	-33.4M	-85.39M	-637K	-23.41M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	232.98M	156.81M	6.04M	49.9M	113.86M	280.03M	74.49M	158.42M	532.82M	-66.67M
FCF Margin %	0.02%	0.02%	0%	0.01%	0.01%	0.03%	0.01%	0.02%	0.05%	-0.01%
FCF Growth %	4.12%	-0.33%	-0.96%	7.27%	1.28%	1.46%	-0.73%	1.13%	2.36%	-1.13%
FCF per Share	3.75	2.57	0.10	0.83	1.88	4.41	0.99	2.08	7.03	-0.87
FCF Conversion (FCF/Net Income)	2.61x	1.72x	0.78x	-0.26x	-2.66x	11.36x	0.56x	14.52x	-17.93x	-0.45x
Interest Paid	0	0	0	68.58M	95.41M	89.96M	38.72M	107.02M	153.25M	141.55M
Taxes Paid	0	0	0	19.15M	6.2M	17.45M	99.4M	33.97M	6.28M	5.55M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	10.43%	11.14%	7.37%	-56.98%	-12.72%	5.09%	26.85%	2.38%	-4.42%	-48.7%
Return on Invested Capital (ROIC)	10.2%	10.91%	4.25%	-15.17%	2.63%	7.98%	14.66%	3.76%	2.32%	-5.43%
Gross Margin	12.43%	12.21%	12.58%	13.89%	12.25%	15.1%	15.46%	18.35%	20.56%	20.74%
Net Margin	1.06%	1.12%	0.78%	-4.44%	-0.68%	0.35%	2.26%	0.22%	-0.4%	-3.39%
Debt / Equity	0.58x	0.59x	0.89x	3.18x	3.70x	1.60x	1.23x	2.95x	2.60x	3.79x
Interest Coverage	7.38x	7.38x	2.81x	-5.52x	0.75x	2.45x	7.66x	1.11x	0.66x	-1.44x
FCF Conversion	2.61x	1.72x	0.78x	-0.26x	-2.66x	11.36x	0.56x	14.52x	-17.93x	-0.45x
Revenue Growth	3.52%	-0.51%	-4.17%	5.59%	-6.38%	-7.93%	15.39%	1.74%	3.8%	3.55%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Products & Healthcare Services	-	-	-	-	-	-	-	7.9B	7.78B	8.02B
Products & Healthcare Services Growth	-	-	-	-	-	-	-	-	-1.48%	3.08%
Patient Direct	-	-	-	-	-	-	-	2.06B	2.55B	2.68B
Patient Direct Growth	-	-	-	-	-	-	-	-	24.09%	5.00%
Global Solutions	-	-	-	9.19B	8.24B	7.21B	7.86B	-	-	-
Global Solutions Growth	-	-	-	-	-10.28%	-12.52%	8.99%	-	-	-
Global Products	-	-	-	1.11B	1.43B	1.81B	2.66B	-	-	-
Global Products Growth	-	-	-	-	29.03%	26.25%	46.70%	-	-	-
Domestic	9.36B	9.19B	8.79B	-	-	-	-	-	-	-
Domestic Growth	-	-1.76%	-4.32%	-	-	-	-	-	-	-
CPS	-	539.58M	504.03M	-	-	-	-	-	-	-
CPS Growth	-	-	-6.59%	-	-	-	-	-	-	-
International	416.81M	343.67M	391.63M	-	-	-	-	-	-	-
International Growth	-	-17.55%	13.95%	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	9.36B	9.34B	8.9B	9.26B	8.87B	8.13B	9.25B	9.53B	10.06B	10.46B
UNITED STATES Growth	-	-0.19%	-4.70%	4.07%	-4.21%	-8.35%	13.77%	2.98%	5.59%	3.97%
Non-US	-	-	-	577.56M	339.34M	349.77M	534.98M	429.44M	275.29M	242.94M
Non-US Growth	-	-	-	-	-41.25%	3.07%	52.95%	-19.73%	-35.89%	-11.75%
Other Europe	132.55M	87.53M	97.92M	-	-	-	-	-	-	-
Other Europe Growth	-	-33.97%	11.88%	-	-	-	-	-	-	-
IRELAND	-	41.21M	56.94M	-	-	-	-	-	-	-
IRELAND Growth	-	-	38.15%	-	-	-	-	-	-	-
GERMANY	46.85M	47.51M	49.23M	-	-	-	-	-	-	-
GERMANY Growth	-	1.42%	3.61%	-	-	-	-	-	-	-
FRANCE	44.59M	38.76M	39.28M	-	-	-	-	-	-	-
FRANCE Growth	-	-13.08%	1.34%	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Owens & Minor, Inc. (OMI) reported $6.71B in revenue for fiscal year 2024. This represents a 22% decrease from $8.63B in 2011.

Owens & Minor, Inc. (OMI) grew revenue by 3.6% over the past year. Growth has been modest.

Owens & Minor, Inc. (OMI) reported a net loss of $1.34B for fiscal year 2024.

Dividend & Returns

Owens & Minor, Inc. (OMI) has a return on equity (ROE) of -48.7%. Negative ROE indicates the company is unprofitable.

Owens & Minor, Inc. (OMI) had negative free cash flow of $352.2M in fiscal year 2024, likely due to heavy capital investments.